These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clinical and genetic analysis of unclassifiable inherited bone marrow failure syndromes. Teo JT; Klaassen R; Fernandez CV; Yanofsky R; Wu J; Champagne J; Silva M; Lipton JH; Brossard J; Samson Y; Abish S; Steele M; Ali K; Athale U; Jardine L; Hand JP; Tsangaris E; Odame I; Beyene J; Dror Y Pediatrics; 2008 Jul; 122(1):e139-48. PubMed ID: 18595958 [TBL] [Abstract][Full Text] [Related]
23. [Study group on bone marrow insufficiency (proceedings)]. Najean Y; Pecking A Nouv Rev Fr Hematol Blood Cells; 1977; 18(3):641-7. PubMed ID: 341082 [No Abstract] [Full Text] [Related]
24. [Hematology in 1975]. Binet JL; Le Porrier M Rev Prat; 1976 May; 26(29):2019-36. PubMed ID: 132696 [No Abstract] [Full Text] [Related]
25. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick HR; Sultan C Ann Intern Med; 1985 Oct; 103(4):620-5. PubMed ID: 3862359 [No Abstract] [Full Text] [Related]
26. [Endocrine insufficiency as a cause of bone marrow failure (author's transl)]. Ferrari E; Bossolo P; Vailati A; Rea A; Sironi PL; Mandelli B; Solerte SB; Pompeo A Haematologica; 1979 Dec; 64(6):812-25. PubMed ID: 121094 [No Abstract] [Full Text] [Related]
27. [Bone marrow insufficiency and dyserythropoiesis in chronic liver disease]. Hernández Nieto L; Batista López JN; Brito Barroso ML; Ravina Cabrera M; Santolaria Fernández FJ; González Brito G Sangre (Barc); 1982; 27(4-B):589-603. PubMed ID: 7157134 [No Abstract] [Full Text] [Related]
30. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Vulliamy TJ; Walne A; Baskaradas A; Mason PJ; Marrone A; Dokal I Blood Cells Mol Dis; 2005; 34(3):257-63. PubMed ID: 15885610 [TBL] [Abstract][Full Text] [Related]
31. [Is Myleran (busulfan) a leukemogenic substance?]. Hunstein W Schweiz Med Wochenschr; 1965 Oct; 95(43):1437-9. PubMed ID: 5880927 [No Abstract] [Full Text] [Related]
32. [Pathological anatomy of panmyelopathy and hypersplenism]. Fischer R; Schaefer HE Internist (Berl); 1971 Apr; 12(4):151-61. PubMed ID: 4928639 [No Abstract] [Full Text] [Related]
33. [Reticulo-endothelial nature of last surviving cells in severe bone marrow aplasia (experimental research)]. Castaldi G; Zavagli G Haematologica; 1971; 56(7):249-64. PubMed ID: 5004568 [No Abstract] [Full Text] [Related]
34. [Histomorphology of bone marrow insufficiency]. Burkhardt R Hamatol Bluttransfus; 1975; 16():112-34. PubMed ID: 1081465 [No Abstract] [Full Text] [Related]
35. [Quantitative study of medullary adipocytes in marrow aplasia (author's transl)]. Heidrecheid N; Charron D; d'Athis P; Raphael M; Binet JL Pathol Biol (Paris); 1979 Apr; 27(4):215-7. PubMed ID: 379759 [TBL] [Abstract][Full Text] [Related]
36. Drug--induced bone marrow injury. Yunis AA Adv Intern Med; 1969; 15():357-76. PubMed ID: 4908623 [No Abstract] [Full Text] [Related]